TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 EUR)
Closing information | 2023/06 | 2021/12 | 2020/12 |
Turnover |
36,859
|
23,848
|
22,500 |
Financial expenses |
120
|
72
|
10 |
Earnings before taxes |
666
|
701
|
571 |
EBITDA |
807
|
791
|
604 |
Total assets |
21,100
|
25,868
|
21,834 |
Current assets |
21,077
|
25,813
|
21,758 |
Current liabilities |
7,389
|
10,617
|
17,655 |
Equity capital |
3,958
|
4,006
|
3,571 |
- share capital |
17
|
20
![]() |
20 |
Employees (average) |
46
|
40
|
38 |
Financial ratios
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Solvency |
18.8%
|
15.5%
|
16.4% |
Turnover per employee |
801
|
596
|
592 |
Profit as a percentage of turnover |
1.8%
|
2.9%
|
2.5% |
Return on assets (ROA) |
3.7%
|
3.0%
|
2.7% |
Current ratio |
285.2%
|
243.1%
|
123.2% |
Return on equity (ROE) |
16.8%
|
17.5%
|
16.0% |
Change turnover |
16,176
|
1,764
|
1,100 |
Change turnover % |
78%
|
8%
|
5% |
Chg. No. of employees |
6
|
2
|
3 |
Chg. No. of employees % |
15%
|
5%
|
9% |
Total value of public sale
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.